American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$276M |
| 2 |
NVIDIA
NVDA
|
+$243M |
| 3 |
Meta Platforms (Facebook)
META
|
+$206M |
| 4 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$165M |
| 5 |
Colgate-Palmolive
CL
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Microsoft
MSFT
|
+$544M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$322M |
| 4 |
L3Harris
LHX
|
+$254M |
| 5 |
Idexx Laboratories
IDXX
|
+$227M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.01% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIGR
2451
UP Fintech Holding
TIGR
$824M
| $134K | ﹤0.01% |
40,978
+4,977
| +14% | +$18.4K |
|
2452
Allogene Therapeutics
ALLO
$697M
| $132K | ﹤0.01% |
26,492
+4,467
| +20% | +$28.6K |
|
2453
Noodles & Co
NDLS
$100M
| $131K | ﹤0.01% |
3,476
+272
| +8% | +$12.4K |
|
2454
Vanda Pharmaceuticals
VNDA
$305M
| $131K | ﹤0.01% |
19,466
-26,247
| -57% | -$185K |
|
2455
MacroGenics
MGNX
$262M
| $130K | ﹤0.01% |
18,265
+3,473
| +23% | +$20.9K |
|
|
FRBK
2456
DELISTED
Republic First Bancorp Inc
FRBK
| $129K | ﹤0.01% |
108,514
+30,720
| +39% | +$60.3K |
|
2457
Ginkgo Bioworks
DNA
$491M
| $128K | ﹤0.01% |
2,609
| – | – |
|
|
ORGN
2458
DELISTED
Origin Materials
ORGN
| $128K | ﹤0.01% |
999
+234
| +31% | +$34.6K |
|
|
ROVR
2459
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $127K | ﹤0.01% |
28,380
+9,173
| +48% | +$37K |
|
|
PGRE
2460
DELISTED
Paramount Group
PGRE
| $127K | ﹤0.01% |
27,879
-79,688
| -74% | -$437K |
|
2461
BioCryst Pharmaceuticals
BCRX
$2.5B
| $125K | ﹤0.01% |
14,950
-192
| -1% | -$1.85K |
|
2462
Editas Medicine
EDIT
$438M
| $123K | ﹤0.01% |
17,530
+3,507
| +25% | +$31.2K |
|
|
AMTD
2463
AMTD IDEA Group
AMTD
$72.2M
| $123K | ﹤0.01% |
26,417
| – | – |
|
2464
XP
XP
$8.18B
| $122K | ﹤0.01% |
10,101
| – | – |
|
2465
Pitney Bowes
PBI
$2.3B
| $119K | ﹤0.01% |
31,614
+15,942
| +102% | +$67K |
|
2466
SiriusXM
SIRI
$9.45B
| $118K | ﹤0.01% |
2,989
-126,285
| -98% | -$6.05M |
|
2467
Quanterix
QTRX
$136M
| $118K | ﹤0.01% |
+10,877
| New | +$139K |
|
|
SHCR
2468
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $116K | ﹤0.01% |
79,279
+43,227
| +120% | +$98K |
|
2469
Magnachip Semiconductor
MX
$139M
| $113K | ﹤0.01% |
12,414
+2,332
| +23% | +$23.1K |
|
|
TSVT
2470
DELISTED
2seventy bio
TSVT
| $111K | ﹤0.01% |
+11,280
| New | +$129K |
|
2471
Janus International
JBI
$684M
| $110K | ﹤0.01% |
+11,300
| New | +$118K |
|
|
ABST
2472
DELISTED
Absolute Software Corp
ABST
| $110K | ﹤0.01% |
14,572
+213
| +1% | +$2.08K |
|
2473
First Bank
FRBA
$469M
| $110K | ﹤0.01% |
+11,024
| New | +$142K |
|
2474
CareDx
CDNA
$2.43B
| $109K | ﹤0.01% |
+12,339
| New | +$158K |
|
2475
Scholar Rock
SRRK
$6.59B
| $109K | ﹤0.01% |
14,222
+3,814
| +37% | +$38.7K |
|
Similar funds
American Century Companies's Q1 2023 Portfolio in Review
As of Q1 2023, American Century Companies held 2,730 positions worth $127B, up 3.7% from $122B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
American Century Companies's Q1 2023 filing shows 153 new, 1,696 increased, 700 reduced and 63 closed positions. Its largest new stake was Atlassian: 260,346 shares worth $44.6M. The largest sale was Amazon, an estimated $615M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q1 2023 buy was Atlassian: 260,346 shares worth $44.6M.
- American Century Companies added most to Humana in Q1 2023, an estimated $276M increase.
- American Century Companies's biggest Q1 2023 reduction was Amazon, cutting an estimated $615M.
- American Century Companies fully exited SVB Financial Group in Q1 2023, selling an estimated $73M.
- American Century Companies's ten largest holdings make up 20% of its $127B portfolio in Q1 2023.
- American Century Companies opened 153 new positions and closed 63 in Q1 2023.
- American Century Companies's portfolio value rose 3.7% quarter-over-quarter to $127B.
Based on American Century Companies's 13F filing for Q1 2023, filed 11 May 2023.